August 14, 2015 | Myriad Genetics' new CEO, Mark Capone, is shifting the company's futures in molecular diagnostics, and competing with a broad new field of companies like Color Genomics and more. He spoke about his view of direct-to-consumer tests and President Obama's Precision Medicine Initiative.
AJMC